Current filters:


7878 to 7887 of 96128 results

Illumina fails in patent litigation with LadaTech


USA-based Illumina (Nasdaq: ILMN) says that a federal jury in Wilmington, Delaware, found that certain…

IlluminaLadaTechLegalNorth AmericaPatentsPharmaceuticalRoche

Abbott unit snaps up LIMS distributors


As part of a series of strategic moves to build its laboratory information management system (LIMS) business…

Abbott LaboratoriesMergers & AcquisitionsPharmaceuticalSTARLIMS

EU Commission proposes faster access to medicines for patients


With the intention of getting new medicines to the market faster, the European Commission yesterday proposed…

EuropeGenericsMarkets & MarketingPharmaceuticalPricingRegulation

GSK and Daiichi Sankyo set up Japanese vaccines JV


UK pharma giant GlaxoSmithKline (LSE: GSK) says it has signed an agreement with Japan's third-largest…

Asia-PacificDaiichi SankyoGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalVaccines

EU Commission finds no evidence against AstraZeneca and Nycomed


The European Commission said yesterday that it has ceased its antitrust investigation into the pharmaceutical…

AstraZenecaEuropeLegalNycomedPatentsPharmaceuticalRegulationTakeda Pharmaceuticals

US FDA delays Eliquis decision; Pristiq dropped for menopause


USA drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE) say that the US Food and…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalPristiqRegulationWomen's Health

IFPMA tightens Code of Practice for health interactions


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice…

BiotechnologyGlobalMarkets & MarketingPharmaceutical

Galapagos leaps on $1.35 billion RA drug deal with Abbott Labs


Belgian drug developer Galapagos (Euronext: GLPG) saw its shares rocket 27% to a record high 13.89 euros…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyGalapagosLicensingPharmaceutical

Biogen Idec files oral MS candidate in USA


US biotech firm Biogen Idec (Nadaq: BIIB) has submitted its orally-active drug for relapsing-remitting…

Biogen IdecBiotechnologyNeurologicalRegulation

7878 to 7887 of 96128 results

Back to top